Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial.

Abdelmalek, M F; Humar, A; Stickel, F; Andreone, P; Pascher, A; Barroso, E; Neff, G W; Ranjan, D; Toselli, L T; Gane, E J; Scarola, J; Alberts, R G; Maller, E S; Lo, C-M

Abdelmalek, M F; Humar, A; Stickel, F; Andreone, P; Pascher, A; Barroso, E; Neff, G W; Ranjan, D; Toselli, L T; Gane, E J; Scarola, J; Alberts, R G; Maller, E S; Lo, C-M.

Affiliation

Abdelmalek MF; University of Florida, Gainesville, FL, USA. manal.abdelmalek@duke.edu

Am J Transplant ; 12(3): 694-705, 2012 Mar.

Article in En | MEDLINE | ID: mdl-22233522

Subject(s)

Calcineurin Inhibitors; Graft Rejection/prevention & control; Graft Survival/drug effects; Immunosuppressive Agents/administration & dosage; Liver Transplantation; Sirolimus/administration & dosage; Adolescent; Adult; Aged; Cyclosporine/administration & dosage; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Prospective Studies; Tacrolimus/administration & dosage; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation / Sirolimus / Calcineurin Inhibitors / Graft Rejection / Graft Survival / Immunosuppressive Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google